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INFANT FEEDING METHOD AND NAS OUTCOMES 2 
Abstract 
 
Background: Neonatal Abstinence Syndrome (NAS) is a complex disorder, observed in infants 
experiencing symptoms of withdrawal, as a result of in utero exposure to the maternal use of 
opioids. Breastfeeding has been recognized as the optimal source of nutrition for infants. While 
the advantages associated with breastfeeding are undisputed, the promotion of breastfeeding for 
infants diagnosed with neonatal abstinence syndrome is inconsistent. There is evidence to 
suggest that breastfeeding infants who have been exposed to opioids in utero may improve NAS 
outcomes.  
Aim: A systematic review was conducted to assess and criticaly appraise the existing literature 
regarding the effect of infant feeding method among infants with Neonatal Abstinence Syndrome 
(NAS) on neonatal outcomes.  
Method: A systematic search of the literature of feeding methods among infants with NAS was 
conducted using the electronic databases Pubmed, CINAHL, Nursing and Alied Health, 
PyschINFO, Evidence Based Medicine, Web of Science, and Medline (EMBASE). Studies were 
eligible for inclusion in the review if they fulfiled the folowing criteria: (1) reported original 
data on outcomes related to infant feeding and NAS, (2) the study method included any type of 
quantitative design that included an inpatient comparison group of breastfed and formula fed 
infants with NAS, and (3) the articles were published in English in a peer reviewed journal. Al 
articles selected for inclusion were assessed for methodological quality by first and secondary 
author using the JBI standardized critical appraisal checklist for cohort/case control studies and 
the JBI standardized critical appraisal checklist for randomized controled studies. The principal 
author extracted the data from the ful text studies and entered it into a data extraction template 
developed for the systematic review. The secondary authors independently reviewed and 
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compared the extracted data. The data was synthesized narratively due to the diverse study 
samples and outcomes that were evaluated.  
Results: The search identified 491 studies, of which 17 provided information related to NAS and 
infant feeding method. Eight studies met the inclusion and exclusion criteria after further 
examination of the ful-text studies. The majority of studies found that breastfeeding was 
associated with a reduced need for pharmacologic treatment and a decrease in the duration of 
pharmacotherapy when compared to formula-fed or combination-fed infants. Breastfeeding, 
when compared to formula-feeding, was also consistently associated with a shorter 
hospitalization and a reduced severity of NAS, including lower Finnegan scores. Studies also 
identified a later time to withdrawal and a delayed onset of NAS associated with breastfed 
infants when compared to formula-fed infants. 
Conclusions and Relevance: The studies consistently identified a trend towards improved NAS 
outcomes for infants who were breastfed when compared to formula or combination-fed. These 
findings provide evidence for breastfeeding as an effective non-pharmacologic treatment for 
NAS. Breastfeeding among stabilized mothers on Opioid Maintenance Therapy (OMT) should 
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Infant Feeding Method and Neonatal Abstinence Syndrome  
 
Outcomes: A Systematic Review 
 
Research has demonstrated the substantial advantages for infants, mothers, and the 
community, from breastfeeding (American Academy of Pediatrics, 2005). Due to the 
considerable benefits associated with human milk, breastfeeding has been recognized as the 
optimal source of nutrition for infants (World Health Organization, 2001). These advantages 
include benefits to infant health, nutrition, immunity, and neurodevelopment, as wel as maternal 
health, and community economic benefits (American Academy of Pediatrics, 2005; Boland, 
2005; World Health Organization, 2001). While the advantages associated with breastfeeding are 
undisputed, the promotion of breastfeeding for infants diagnosed with neonatal abstinence 
syndrome (NAS) is inconsistent (Jansson, Velez, & Harrow, 2004). Understanding the evidence 
regarding breastfeeding for infants with NAS is an important consideration for clinicians to 
promote this method of feeding. As such, the purpose of this systematic review was to assess and 
criticaly appraise the existing literature regarding the effect of infant feeding method among 
infants with NAS on neonatal outcomes. This review method was selected to provide a thorough 
overview of the current literature and to alow for the inclusion of a variety of methodologies, 
different scoring tools to measure symptomology, and diverse NAS outcomes.  
Background 
Neonatal Abstinence Syndrome (NAS) is a complex disorder, observed in infants 
experiencing symptoms of withdrawal, as a result of in-utero exposure to the maternal use of 
opioids (Stover & Davis, 2015; Sublet, 2013). Neonatal Abstinence Syndrome is a multisystem 
condition that presents as hyperirritability of the central nervous system, autonomic dysfunction, 
and gastrointestinal disturbances (Kocherlakota, 2014; Stover & Davis, 2015). The symptoms of 
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NAS are characterized, but not limited to vomiting, loose stools, poor feeding, tremors, high-
pitched crying, altered sleep-wake cycles, seizures, respiratory distress, and temperature 
instability (Finnegan, Connaughton, Kron, & Emich, 1975; Kocherlakota, 2014; Sublet, 2013). 
The manifestation of symptoms varies among infants, and the onset, duration, and severity of 
NAS depend on a number of factors (Kocherlakota, 2014). Neonatal Abstinence Syndrome may 
be affected by the substance ingested by the mother, the time of the last dose, in-utero duration 
of exposure, and maternal and placental metabolism (Hudak & Tan, 2012). The diagnosis of 
NAS is based on symptoms of neonatal withdrawal, rather than the need for pharmacotherapy 
(Kraft, Stover, & Davis, 2016). The onset of NAS symptoms is typicaly observed within the 
first 24-72 hours (Hudak & Tan, 2012).  
One method to assess the severity of NAS symptoms is through the use of scoring tools. 
Scoring tools are used to objectively evaluate the infant for the severity of NAS symptoms, guide 
pharmacotherapy, and assist in the structured process of weaning (McQueen & Murphy-
Oikonen, 2016). Curently, the Finnegan Neonatal Abstinence Scoring Tool is the most 
commonly used tool, in either its 1975 original format or the modified short form version 
(Finnegan et al., 1975; Finnegan, 1986). Other tools have been used to score severity of 
symptoms and guide pharmacologic treatment of NAS, but the Finnegan Neonatal Abstinence 
Scoring Tool remains the most comprehensive (Wiles, Isemann, Ward, Vinks, & Akinbi, 2014). 
Regardless of the tool used, inter-observer reliability is an important consideration, due to the 
subjectivity of the assessment (Kocherlakota, 2014).  
Studies have suggested that the incidence of NAS is on the rise. In the United States, for 
every 1000 hospital births annualy, the diagnosis of infant NAS grew from 1.20 to 3.39 between 
2000 and 2009 (Patrick et al., 2012). Correspondingly, there was an increase in maternal use or 
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dependence on opiates from 1.19 in 2000 to 5.63 in 2009 for every 1000 hospital births per year 
(Patrick et al., 2012). Western Australia (O’Donnel et al., 2009) and Canada (Davies et al., 
2016; Dow et al., 2012) have observed similar increases. The etiology of NAS has also had 
considerable changes over time. In the last 40 years, the precursor of NAS has shifted from 
primarily being a result of ilicit opiate use, to now being inclusive of opioid replacement therapy 
(ORT) such as methadone and buprenorphine (Hudak & Tan, 2012; Kieviet, Dolman, & Honig, 
2013). The rise in opiate use, coupled with the complication of simultaneous licit and ilicit 
substances has led to NAS becoming increasingly common and complex (Kocherlakota, 2014). 
Several adverse outcomes have been associated with NAS. Between 2004 and 2013 the 
number of infants admited to NICU in the USA for NAS increased from 7 to 27 admissions for 
every 1000 hospital births (Tolia et al., 2015). The use of pharmacotherapy as a form of NAS 
treatment also increased from 74% to 87%, with simultaneous growth in the pharmacological 
duration of treatment (Tolia et al., 2015). Due to the management of withdrawal symptoms 
through pharmacologic treatment, admission to the NICU and lengthy hospitalizations are often 
required (Hudak & Tan, 2012; Wachman et al., 2011). Separation of mother and her infant at a 
critical time for bonding (Abrahams et al., 2010), and overal decreased rates of breastfeeding 
(Wachman, Byun, & Philipp, 2010) in this population are added negative outcomes associated 
with NAS.  
While the needs of each infant are unique, the treatment of infant NAS symptoms often 
folows an approach based on pharmacological drug treatment, with oral morphine or methadone 
recommended as a first-line medication to treat withdrawal (McQueen & Murphy-Oikonen, 
2016; Wiles et al., 2014). Although pharmacotherapy has been wel researched, there is a 
growing body of evidence regarding the impact of infant feeding method on NAS outcomes. 
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Furthermore, breastfeeding has been established as compatible for mothers stabilized on ORT 
with no contraindications (McQueen & Murphy-Oikonen, 2016; O’Connor, Colet, Alto, & 
Brien, 2013). Research has suggested that methadone concentrations found in human milk are 
low, and women on stable doses of methadone should be encouraged to breastfeed, regardless of 
maternal methadone dose (McCarthy & Posey, 2000). Despite this indication, the promotion of 
breastfeeding for NAS infants is inconsistent and varies across hospitals (Jansson, 2009; 
Provincial Council for Maternal and Child Health, 2012). This systematic review wil assess and 
criticaly appraise the existing literature regarding the effect of infant feeding method among 
infants with NAS on neonatal outcomes. 
Method 
Search Strategy 
The electronic databases Pubmed, CINAHL, Nursing and Alied Health, PsychINFO, 
Evidence-Based Medicine, Web of Science, and Medline (EMBASE) were searched from 1990 
to February 2018. Subject terms used in the search strategy included ‘neonatal abstinence 
syndrome’ [MeSH] and one of the folowing additional terms, breast feeding [MeSH], 
breastfeed*, or infant formula [MeSH]. To ensure relevant articles had not been missed, the 
reference lists of included studies were reviewed for additional articles relevant to the initial 
search. A forward citation search of included studies was completed July 1st, 2018 and yielded 
no additional articles.  
Study Selection 
The review folowed the Prefered Reporting Items for Systematic Reviews and Meta-
analysis (PRISMA) statement (Figure1) (Moher et al., 2009). Studies were eligible for inclusion 
in the review if they fulfiled the folowing criteria: 1) reported original data on outcomes related 
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to breastfed and formula fed infants with NAS, 2) the study method included any type of 
quantitative design that included an inpatient comparison group of breastfed and formula fed 
infants with NAS, and 3) the articles were published in English in a peer reviewed journal. For 
the purpose of this review, NAS was defined as a postnatal withdrawal syndrome in infants that 
were exposed to opioids in utero (McQueen & Murphy-Oikonen, 2016). Thus, NAS in infants 
exclusively from substances other than opioids (e.g., Selective Serotonin Reuptake Inhibitors) 
were excluded from this review. Additional exclusion criteria included: 1) descriptive studies 
with no comparison of breastfed and formula fed infants with NAS, 2) review articles and 3) 
infants who were re-admited to hospital with NAS after discharge.  
The first author entered al studies from the search into the Zotero Reference Manager 
and removed duplicates. The remaining studies were screened for inclusion based on the title and 
abstract by both the first (CT) and second author (JM). Remaining ful text articles were 
independently reviewed by al authors and inclusion criteria was discussed until agreement was 
achieved. Articles that did not meet the inclusion and exclusion criteria were eliminated for 
further review. 
Data Extraction 
The principal author extracted the data from the ful text studies and entered it into a data 
extraction template developed for the systematic review. The template included the authors’ 
names, year of publication, country, purpose, definition of feeding method, study design, sample 
size, infant feeding method, in-utero drug exposure, infant treatment, and NAS outcomes. The 
second and third authors (JM and KM) independently reviewed and compared the extracted data. 
All differences were discussed, referring back to the article until an agreement was obtained. 
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Assessment of Methodological Quality  
Al articles selected for inclusion were assessed for methodological quality by the first 
and secondary authors (CT & JM) using the Joanna Briggs Institute (JBI) standardized critical 
appraisal checklist for cohort/case control studies and the JBI standardized critical appraisal 
checklist for randomized controled studies (Joanna Briggs Institute, 2014). Studies were 
evaluated as having a low, moderate, or high risk of bias based on the selection of participants, 
measures of NAS outcomes, confounding factors, and folow-up care. CT and JM independently 
reviewed and compared the assessments, and any disagreements were resolved through 
discussion with the third author KM until an agreement was obtained. No studies were 
eliminated based on the critical appraisal.  
Data Synthesis  
 The data was synthesized narratively due to the diverse study samples and outcomes that 
were evaluated. Outcomes evaluated included requirement for pharmacologic treatment, duration 
of pharmacology, length of hospital stay, and NAS severity scores and time to withdrawal. 
Results 
The search identified 491 studies, of which 17 provided information related to NAS 
outcomes and infant feeding method. Further assessment of the inclusion and exclusion criteria 
eliminated 9 of the studies due to: descriptive studies/no comparison group (n=1); no NAS 
outcome data (n=3); NAS included substances other than opioids (n=2); no infant feeding 
method data (n=2); and conference abstract (n=1). A total of 8 articles met al criteria and are 
included in the review. See Figure 1 for the PRISMA flow diagram. 
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Study Characteristics  
The characteristics of the eight included studies are provided in Appendix A. Al of the 
studies were published between 2006 and 2018, with population samples from 5 countries 
including Australia (n=2), Canada (n=1), Norway (n=1), the United States (n=3), and Scotland 
(n=1). The primary purpose for five of the studies was to evaluate the effect of infant feeding 
method on NAS outcomes (Abdel-Latif et al., 2006; Lui, Juarez, Nair, & Nanan, 2015; 
McQueen, Murphy-Oikonen, Gerlach, & Montelpare, 2011; O’Connor et al., 2013; Wele-Strand 
et al., 2013). The other three studies reported NAS outcomes in relation to infant feeding 
method, although it was not the primary purpose of the study (Isemann, Meinzen-Derr, & 
Akinbi, 2010; Jansson et al., 2007; MacVicar, Humphrey, & Forbes-McKay, 2017). Six of the 
studies were retrospective cohort reviews (Abdel-Latif et al., 2006; Isemann et al, 2010; Lui et 
al., 2015; McQueen et al., 2011; O’Connor et al., 2013) with one of these studies also including a 
prospective review (Wele-Strand et al., 2013). One study was a matched design (Jansson et al., 
2007), and one study was mixed methods including a randomized control trial (MacVicar et al., 
2017). 
Sample sizes ranged from 14 to 194 mother-infant dyads. Categorization of infant 
feeding method was based on self-selected samples. However, the definition of breastfeeding 
varied between studies and one study did not clearly define the feeding method (Isemann et al., 
2010). This is an important consideration, as the feeding method in relation to NAS outcomes is 
evaluated. The prevalence of breastfeeding ranged from 23% to 79%. It is important to consider 
the variation in breastfeeding rates may be related to the definition of breastfeeding in select 
studies, with breastfeeding defined as ongoing atempts to latch onto the breast, infants who 
received breastmilk at birth and postpartum even if they were also given formula, and self-
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reported initiation and continuation of breastfeeding (MacVicar, 2017; O’Connor et al., 2013; 
Wele-Strand, 2013).  
Al infants were exposed to opioid maintenance therapy (OMT) in utero, including 
methadone (n=5), buprenorphine (n=1) and either methadone or buprenorphine (n=2). The 
primary medications used for pharmacologic treatment of NAS was morphine (n=1), 
phenobarbital (n=1), either morphine or phenobarbital (n=1), methadone or phenobarbital (n=1), 
and diluted tincture of opium or morphine (n=1). Three studies did not specify the 
pharmacologic treatment for NAS (see Appendix A). 
The Finnegan or a modified version of the Finnegan Scoring Tool was used in al of the 
studies to assess symptoms of NAS and to guide pharmacologic treatment. However, the studies 
differed in their evaluation of requirement for pharmacologic treatment. Three studies initiated 
pharmacologic treatment folowing two consecutive Finnegan Scores greater than 8 (Abdel-latif 
et al., 2006; Isemann et al., 2010; Jansson et al., 2007). Two studies initiated pharmacologic 
treatment folowing three consecutive Finnegan Scores greater than 8 (McQueen et al., 2011; 
O’Connor et al., 2013) and three studies did not report the initiation of pharmacologic treatment 
in relation to NAS Finnegan Scores (Lui et al., 2015; MacVicar et al., 2017; Wele-Strand et al., 
2013). Furthermore, the modifications of the tool and/or the number of items were not specified 
in the studies. Al studies explored one or more NAS outcomes including requirement for 
pharmacologic treatment, overal duration of pharmacotherapy, hospital length of stay, and NAS 
severity (see Appendix B). 
Methodological Quality  
Five studies were identified as a low risk of bias (Abdel-latif et al., 2006; Isemann et al., 
2010; Jansson et el., 2007; Lui et al., 2015; MacVicar et al., 2017) and three studies were 
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identified as a moderate risk of bias (McQueen et al., 2011; O’Connor et al., 2013; Wele-Strand 
et al., 2013). Infant feeding method was self-selected by mothers. Thus, selection bias was 
present in six of the seven studies appraised with JBI standardized critical appraisal checklist for 
cohort/case control studies (Abdel-latif et al., 2006; Isemann et al., 2010; Lui et al., 2015; 
McQueen et al., 2011; O’Connor et al., 2013; Welle-Strand et al., 2013). In one study, selection 
bias was not present as the groups were matched with respect to race, parity (primiparous versus 
multiparous), age within 5 years, and methadone dose within 10mg (Jansson et el., 2007). 
Selection bias was not present in the randomized control trial study, as a computer-generated 
process was used for true randomization of participants to groups (MacVicar et al., 2018). The 
majority of the studies identified criteria for categorization of infant feeding method, which 
included breastfeeding, expressed breastmilk, combination feeding, and formula feeding. 
However, the definition and categorization of infant feeding method varied between studies. Al 
studies identified using the Finnegan Scoring Tool or a Modified Finnegan to assess NAS and 
guide pharmacologic treatment. However, the studies differed in protocols for pharmacological 
initiation and the validity and reliability of the tool was not indicated in most studies. Thus, 
measurement bias was probable.  
Most studies identified confounding factors, including maternal and infant baseline 
characteristics (maternal OMT, polydrug use, smoking, parity, birth weight, and gestation) and 
the majority of studies made adjustments in data analysis to account for the confounding factors 
measured. Finaly, due to the majority of the studies being conducted in hospital, the atrition 
bias was unlikely, and is an overal strength (see Appendix C and D). 
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Infant Feeding Method and NAS Outcome: Pharmacology 
Al studies reported NAS outcomes in relation to pharmacology, including the need for 
pharmacologic treatment and/or the duration of pharmacotherapy for NAS (see Appendix B). 
Among the studies (n=7) evaluating infants who received pharmacologic treatment, two studies 
reported breastfed infants were significantly less likely to require pharmacologic treatment 
compared to formula-fed infants (Abdel-Latif et al., 2006; Wele-Strand et al., 2013). Four 
studies found that breastfed infants were less likely to require pharmacologic treatment when 
compared to formula-fed or combination-fed infants; however, the results were not statisticaly 
significant (Jansson et al., 2007; MacVicar, 2017; McQueen et al., 2011; O’Connor et al., 2013). 
One study reported no statistical difference in the incidence of pharmacologic treatment when 
comparing methods of feeding (Lui et al., 2015), and one study did not evaluate the likelihod of 
requiring pharmacologic treatment for NAS (Isemann et al., 2010). 
Three studies evaluated the duration of pharmacologic treatment. In two of the studies, 
researchers identified statisticaly significant diferences in the mean duration of NAS treatment 
between groups (Abdel-Latif et al., 2006; Wele-Strand et al., 2013). Overal, Wele-Strand et al. 
(2013) reported al breastfed infants of women on OMT had a statisticaly significant shorter 
mean pharmacologic treatment for NAS (28.6 days + 19.1) in contrast to formula-fed infants of 
women in OMT (46.7 days + 27.2; p = <0.05). Wele-Strand et al. (2013) further identified a 
statisticaly significant shorter mean pharmacologic treatment for breastfed infants of mothers in 
MMT (31 days + 21.4) when compared to formula-fed infants of women in MMT (48.9 days + 
27.2; p = <0.05). However, no diferences in duration were found in the buprenorphine-exposed 
infants. Although not statisticaly significant, Abdel-Latif et al. (2006) also found that breastfed 
infants had a shorter mean duration of NAS treatment (85 days + 71.7) when compared to 
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formula-fed infants (108.2 days + 81.8; p = .185). Similarly, Isemann et al. (2010) reported 
differences in the median duration of pharmacologic treatment for NAS, with breastfed infants 
having a shorter median duration of pharmacotherapy (10.8 days) when compared to formula-fed 
infants (12.4 days; p < .35); however, the results were not reported as statisticaly significant.  
Infant Feeding Method and NAS Outcome: Length of Stay 
 Length of hospital stay was evaluated in four of the eight studies (see Appendix B). 
Among infants with NAS, two studies found that breastfed infants had a statisticaly significantly 
reduced length of stay in hospital when compared to formula-fed infants (Abdel-Latif et al., 
2006; Isemann et al., 2010). A shorter median hospital stay was identified for breastfed infants 
(12.5 days; ranging from 3-51 days) when compared to formula-fed infants (18.5 days; ranging 
from 9 to 43 days; p = 0.01) (Isemann et al., 2010). Similarly, Abdel-Latif et al. (2006) found 
breastfed infants had a shorter mean hospital stay (14.7 days + 14.9) when compared to formula-
fed infants (19.1 days + 15.0; p = .049). MacVicar et al. (2017) also found the mean hospital stay 
was shorter for breastfed infants (10.8 days + 6.7) when compared to formula-fed infants (30.0 
days + 11.8), however, the significance of the results was not reported. Although, O’Connor et 
al. (2013) also evaluated the mean hospital stay for breastfed (7.08 days + 4.4) and formula-fed 
infants (6.6 days + 1.7; p = .35), no conclusions were drawn due to complications unrelated to 
NAS in the group of breastfed infants. 
Infant Feeding Method and NAS Outcome: NAS Severity  
 Severity of NAS symptoms was evaluated in four of the eight studies (see Appendix B). 
Of the four studies that evaluated NAS severity, al reported outcomes related to mean Finnegan 
scores between groups (Abdel-Latif et al., 2006; Lui et al., 2015; McQueen et al., 2011; 
O’Connor et al., 2013). Abdel-Latif et al. (2006) reported mean Finnegan scores for the first 9 
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days of life were lower in breastfed infants when compared to formula-fed infants (p < .05). 
Likewise, McQueen et al. (2011) reported mean Finnegan scores were lower in breastfed infants 
(4.9 + 2.9) when compared to combination-fed (6.5 + 3.7) and formula-fed infants (6.9 + 4.2; p = 
.0001). Correspondingly, the mean number of Finnegan scores recorded was also lower in 
breastfed infants (25 + 23.5) when compared to combination-fed (56.2 + 39.1) and formula-fed 
infants (95.9 + 34.69; p = .001) (McQueen et al., 2011). Alternatively, Lui et al. (2015) found no 
statistical difference in mean NAS scores of breastfed infants (5.1 + 1.3), expressed breastmilk 
(5.7 + 0.9) and formula-fed (5.4 + 1.1; p = 0.47). Although the results were not reported as 
significant, O’Connor et al. (2013) reported breastfed infants were less likely to score 8 or above 
on the Finnegan Scoring Tool, as wel as less likely to score 12 or above when compared to 
formula-fed infants. Similarly, McQueen et al. (2011) reported a lower mean area of Finnegan 
scores for breastfed infants (7.7 + 3.5) compared to combination-fed (12.4 + 4.2) and formula-
fed (11.4 + 2.9; p = .04). While O’Connor (2013) reported lower mean Finnegan peak scores and 
a shorter mean Finnegan time to peak for breastfed infants when compared to formula-fed 
infants, neither of these results were reported as statisticaly significant. 
 Time to NAS withdrawal was also evaluated in two of the eight studies (Abdel-Latif et 
al., 2006; Lui et al., 2015) with longer time to the onset of symptoms among breastfed infants. 
Breastfeeding during the first 2 days of life was significantly associated with a delayed onset of 
NAS among infants of MMT mothers (p=.04) (Lui et al., 2015). Similarly, the median time to 
withdrawal occurred later in breastfed infants (10 days) when compared to formula-fed infants (3 
days; p = .001) (Abdel-Latif, 2006). Overal, mean Finnegan scores were consistently reported as 
lower in breastfed infants when compared to formula-fed infants with NAS, which suggests 
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breastfed infants have a delayed onset or a later time to withdrawal when compared to formula-
fed infants. 
Discussion 
The purpose of this systematic review was to assess and criticaly appraise the existing 
literature regarding the effect of infant feeding method among infants with Neonatal Abstinence 
Syndrome. The studies consistently identified a trend towards improved NAS outcomes for 
infants who were breastfed. The majority of studies found that breastfeeding was associated with 
a reduced need for pharmacologic treatment and a decrease in the duration of pharmacotherapy 
when compared to formula-fed or combination-fed infants. Breastfeeding, when compared to 
formula-feeding, was also consistently associated with a shorter hospitalization and a reduced 
severity of NAS, including lower Finnegan scores. Studies also identified a later time to 
withdrawal and a delayed onset of NAS associated with breastfed infants when compared to 
formula-fed infants. These findings were consistent regardless of the in utero opioid exposure or 
infant treatment type. It is important to note that breastfeeding has been shown to promote 
atachment, and appears to sooth agitated infants (Abdel et al., 2006). Breastfeeding has also 
been suggested as an intervention for the management of NAS infant symptoms (Jansson et al., 
2004) thus, proposing that a mothers’ breastmilk may have a weaning efect.  
While breastfeeding has been associated with positive outcomes for NAS infants, 
breastfeeding rates among mothers of infants with NAS are low when compared to the rates of 
breastfeeding among non-substance users (Pritham, 2013). Researchers have identified a number 
of chalenges that exist for the opioid-dependent mother and her infant. NAS is related to feeding 
difficulties, including nasal stuffiness, uncoordinated movements, and complications with 
sucking (Jansson, Velez, & Butz, 2017), which may impact a mother’s ability to initiate or 
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successfuly breastfeed. Outcomes related to NAS often lead to a separation of mother and her 
infant at a critical time for bonding, including an increased risk for admission to the NICU, 
prolonged hospital stay, and the use of pharmacotherapy (Tolia et al., 2015). These outcomes and 
the increased likelihood of mother and infant separation may create potential barriers to 
breastfeeding. Further bariers to breastfeeding in this population include a lack of information or 
inconsistent promotion of breastfeeding by healthcare professionals (Jansson, 2009; McQueen & 
Murphy-Oikonen, 2016). Thus, suggesting that despite the benefits of breastfeeding, structural 
barriers may decrease rates of breastfeeding in this population.  
Understanding the influences surrounding a woman’s decision to breastfeed is another 
important consideration. Feelings of guilt and distress may be experienced by many opioid-
dependent mothers due to their infant’s in utero exposures and NAS symptomology, which may 
create chalenges surrounding a mother’s decision to breastfeed (Pritham, 2013; Velez & 
Jansson, 2008). Some additional factors that contribute to the decision to breastfeed include 
knowledge of breastfeeding, current physical and mental health, and social influence (Pritham, 
2013). Patrick et al. (2012) suggest that the majority of opioid-dependent pregnant women are 
socioeconomicaly disadvantaged. Low socioeconomic status along with marital status, age and 
education also appear to play a role in influencing a mother’s decision to breastfeed (Pritham, 
2013). Additionaly, there is a complexity surrounding the mother-infant dyad, particularly when 
the mother has a substance use disorder and a sexual abuse history (Jansson, Velez, & Butz, 
2017). Survivors of sexual abuse may experience a distorted view of the dual role of their breasts 
as both sexual and maternal objects, thus contributing to issues surrounding the decision of 
breastfeeding in this population (Jansson, Velez, & Butz, 2017). Given both the structural and 
personal barriers to breastfeeding, and the importance of the postnatal period for mother-infant 
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bonding and atachment (Shannon, Blythe, & Peters, 2016; Tolia et al., 2015), an increased 
understanding surrounding the evidence of breastfeeding for NAS is crucial for consistent 
promotion of this method of feeding. The included studies of this systematic review have 
consistently supported positive outcomes associated with breastfeeding when compared to 
formula or combination-fed infants. 
Limitations  
Although breastfeeding was consistently associated with positive NAS outcomes among 
diverse populations, various methodological weaknesses were evident. Six of the eight included 
studies relied on the accuracy of medical records through a retrospective design. The other two 
included studies were a smal sample matched design and a mixed methods pilot study, both of 
which did not evaluate NAS outcomes in relation to feeding method, as the primary purpose. 
Furthermore, two of the included studies did not identify a clear definition of the categorization 
of feeding method, which is an important consideration, as the NAS outcomes were compared 
between feeding modalities. A number of studies had smal sample sizes, and the in-utero opioid 
exposure and postnatal infant treatment varied between studies. While limitations were apparent, 
the critical appraisal identified that the majority of the included studies (n = 5) were a low risk of 
bias for cohort studies. Despite these limitations, consistent trends were found that suggest that 
breastfeeding is associated with positive NAS outcomes, including a reduced need and duration 
of pharmacologic treatment, shorter hospitalization, delayed onset of NAS, and a reduced 
severity of NAS, including lower Finnegan scores.  
Implications for Practice 
These findings have important clinical implications and suggest that breastfeeding may 
be an effective non-pharmacologic intervention in the treatment of infants with NAS. As such, 
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breastfeeding should be encouraged among mothers on OMT, where no other contraindications 
for breastfeeding are present (McQueen & Murphy-Oikonen, 2016; Pritham, 2013). It is 
important to consider that the promotion of breastfeeding in this population is inconsistent 
(Jansson, Velez, Harrow, 2004). Thus, gaps in knowledge may exist among healthcare providers 
regarding breastfeeding compatibility, contraindications, and the potential benefits of 
breastfeeding in this population. Education of healthcare providers may assist in promoting 
breastfeeding in opioid-dependent mothers when contraindications are not present. Early and 
consistent maternal education surrounding the benefits of breastfeeding, including the potential 
to improve NAS outcomes is needed, as this knowledge may increase breastfeeding initiation 
and duration in this population. In hospital supports and folow-up services may be beneficial to 
both mother and infant, however further research is necessary to determine effective 
interventions to support mothers on OMT. 
Implications for Future Research  
The findings from this systematic review have implications for future research. Larger 
studies, with a prospective design, are necessary to continue to assess the effect of infant feeding 
method on NAS outcomes. Future research which compares different OMT in relation to feeding 
method and NAS outcomes is an important consideration to expand the knowledge surrounding 
this population. To further understand both the structural and personal bariers to breastfeeding 
in this population, qualitative research which explores the experiences and perceptions of opioid-
dependent mothers is needed. In addition, research to determine effective interventions to 
support mothers on OMT with breastfeeding is warranted.  
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Conclusion 
The results from this systematic review suggest that breastfeeding has the potential to 
improve NAS outcomes, including a decreased incidence of pharmacologic need for NAS 
treatment, a shorter duration of pharmacotherapy, a reduction in hospital stay, and reduced NAS 
severity and time to withdrawal. While the studies consistently report improved NAS outcomes, 
chalenges exist in this population, and consideration to a mother’s poly-substance use and other 
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through forward citation search 
(n = 0) 
Records after duplicates removed 
(n = 363) 
Title and Abstract 
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(n = 346) 
Primarily re: no breastfeeding 
outcomes; not a primary study; 
not NAS 
 
Ful text articles 
assessed for eligibility  
(n = 17) 
Studies included in 
quantitative synthesis  
(n = 8) 
Ful-text articles excluded 
re:  
(n = 1) descriptive 
studies/no comparison 
group 
(n = 3) no NAS outcome 
data 
(n = 2) NAS included 
substances other than 
opioids 
(n = 2) no infant feeding 
method data 
(n = 1) conference 
abstract 
 (n = 9) 
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Appendix I – JBI Critical Assessment of Selected Articles – Comparable Cohort/Case Control 
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Lui et al. 
(2015) 
 
N Y Y Y Y Y U Y Y N/A Y 8/10 
McQueen 
et al.  
(2011) 








N N Y Y Y Y N Y Y N/A Y 7/10 
Total (%) 14.3 71.4 100 100 71.4 100 42.9 100 100 N/A 85.7  
 
Appendix II – JBI Critical Assessment of Selected Articles – Randomized Controled Trials  
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Appendix B – NAS Outcomes  
Author/ 
Year 
Pharmacology Length of Stay NAS Severity 
Treatment Duration Scores Time to Withdrawal 
Abdel-
Latif et al. 
(2006) 
Breastfed infants were less 
likely to require 
pharmacologic treatment 
(45 of 85 infants; 52.9%) 
compared to formula-fed 
(83 of 105 infants; 79.0%), 
p < .001) 
Breastfed infants had a 
shorter mean duration of 
NAS treatment (85 days + 
71.7) compared to formula-
fed (108.2 days + 81.8; p = 
.185) 
Breastfed infants had a 
shorter mean hospital stay 
(14.7 days + 14.9) 
compared to formula fed 
(19.1 days + 15.0; p = 
.049) 
 
Mean Finnegan Scores 
for the first 9 days of life 
were lower in breastfed 
infants compared to 
formula-fed (p < .05) 
 
Median time to 
withdrawal occured 
later in breastfed infants 
(10 days) compared to 





Not Evaluated  Breastfed infants had a 
shorter median duration of 
methadone pharmacotherapy 
(10.8 days) compared to 
formula-fed (12.4 days; p < 
.35). Result not statisticaly 
significant.  
 
Breastfed infants had a 
shorter median hospital 
stay (12.5 days; ranging 
from 3-51 days) compared 
to formula-fed (18.5 days; 
ranging from 9 to 43 days; 
p = .01) 
 
Not Evaluated  Not Evaluated  
Jansson et 
al. (2007) 
Breastfed infants were less 
likely to require 
pharmacologic treatment 
(1 of 8 infants; 12%) 
compared to formula-fed 
(4 of 8 infants; 50%), p = 
.28) 
 
Not Evaluated  Not Evaluated  Not Evaluated  Not Evaluated  
Lui et al. 
(2015) 
 
No statistical diference in 
the incidence of 
pharmacologic need for 
NAS treatment for 
breastfed (23 of 32 infants; 
72%), expressed breast 
milk (12 of 12 infants; 
100%) and formula-fed 
(121 of 150 infants; 81%), 
p = .11)  
 
 
Not Evaluated  Not Evaluated  No statistical diference 
in mean NAS scores of 
breastfed infants (5.1+ 
1.3), expressed breast 
milk (5.7 + 0.9) and 
formula-fed (5.4 + 1.1), p 
= 0.47) 
 
Breastfeeding during the 
first 2 days of life was 
associated with a delayed 
onset of NAS (p = 0.04). 
Cox Regression Analysis 
used to determine 
variables predictive of 
time to onset of NAS 
among infants of MMT 
mothers.   
                                                              




Breastfed infants were less 
likely to require 
pharmacologic treatment 
(3 of 11 infants; 27%) 
compared to formula-fed 
(3 of 3 infants; 100%). 
P value not reported.  








Breastfed infants had a 
shorter mean hospital stay 
(10.8 + 6.7 days) 
compared to formula-fed 
infants (30.0 + 11.8 days). 
P value not reported.  




Breastfed infants were less 
likely to require 
pharmacologic treatment 
(17%) compared to 
formula-fed (38.8%) and 
combination-fed (40.2%) 
 
Not Evaluated  Not Evaluated  Breastfed infants had a lower 
mean number Finnegan 
scores recorded (25 + 23.5) 
compared to combination-fed 
(56.2 + 39.1) and formula-fed 
(95.9 + 34.69; p = .001)  
 
Mean Finnegan Scores were 
lower in breastfed infants (4.9 
+ 2.9) compared to 
combination-fed (6.5 + 3.7) 
and formula-fed (6.9 + 4.2; p 
= .0001) 
 
Breastfed infants had a lower 
mean area Finnegan Score 
(7.7 + 3.5) compared to 
combination-fed (12.4 + 4.2) 
and formula-fed (11.4 + 2.9; 
p = .04) 
 




Breastfed infants were less 
likely to require 
pharmacologic treatment 
(15 of 65 infants; 23%) 
compared to formula-fed 
(6 of 20 infants; 30%), p = 
.56) 
Not Evaluated  Breastfed infants had a 
variable mean hospital stay 
(7.08 days + 4.4) 
compared to formula-fed 
(6.6 + 1.7; p = .35) due to 
complications unrelated to 





Mean Finnegan peak scores 
was lower in breastfed infants 
(8.83 + 3.56) compared to 
formula-fed (9.65 + 2.58; p = 
.17) 
 
Mean Finnegan time to peak 
scores was shorter in 
breastfed infants (66.5 + 
43.8) compared to formula-
fed (73.5 + 41.82; p = .32) 
Not Evaluated  
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Breastfed infants were less 
likely to score 8 or above on 
Finnegan tool (65%) 
compared to formula-fed 
(75%), p = NS) 
 
Breastfed infants were less 
likely to score 12 or above on 
Finnegan tool (17%) 
compared to formula-fed 





Breastfed infants in the 
methadone-exposed group 
were less likely to require 
pharmacologic treatment 
(44 of 95 infants; 53%) 
compared to formula-fed 
(23 of 29 infants; 80%), p 
= <0.05)  
 
For buprenorphine-
exposed infants, no 
diference was found in the 
incidence of 
pharmacologic need for 
NAS treatment for 
breastfed (61 of 95 infants; 
64%) compared to 
formula-fed infants (13 of 




Breastfed infants of women 
in OMT had a shorter mean 
duration of NAS treatment 
(28.6 days + 19.1) compared 
to formula-fed (46.7 days + 
26.3; p = <0.05) 
 
Breastfed infants of women 
in MMT had a shorter mean 
duration of NAS treatment 
(31 days + 21.4) compared 
to formula-fed (48.9 days + 
27.2; p = <0.05) 
 
For buprenorphine-exposed 
infants, no diference was 
found in duration of NAS 
treatment for breastfed 
infants (25.7 days + 16.0) 
compared to formula-fed 
(38.8 days + 24.0; p = NS) 
 
Not Evaluated  Not Evaluated  Not Evaluated  
 
 
 
 
 
